Endonovo Therapeutics Announces Reverse Stock Split - UPDATE
11 déc. 2019 13h40 HE
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Dec. 11, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), announced today it has determined to effect a 1-for-1,000 reverse stock...
Endonovo Therapeutics Announces Reverse Stock Split
11 déc. 2019 12h47 HE
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Dec. 11, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), announced today it has determined to effect a 1-for-1,000 reverse stock...
Endonovo Therapeutics Announces Reverse Stock Split
31 oct. 2019 12h43 HE
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Oct. 31, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced that it had filed a preliminary information statement...
Endonovo Therapeutics Appoints Dr. William Li as Strategic Advisor to the CEO
30 sept. 2019 09h00 HE
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announces it has appointed Dr. William Li as Strategic Advisor to...
Endonovo Therapeutics Announces Receipt of Notice of Allowance from the United States Patent and Trademark Office
18 déc. 2018 09h25 HE
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapies...
Endonovo Expands SofPulse Commercialization
13 déc. 2018 09h20 HE
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapies,...